Aicardi-Goutières syndrome

Area of Science:

• Genetics
• Immunology
• Neurology

Background:

• Aicardi-Goutières syndrome (AGS) is a genetic encephalopathy with overlapping features of congenital infections and systemic lupus erythematosus (SLE).
• Mutations in five genes are known causes of AGS, often inherited recessively but sometimes dominantly.
• Both AGS and SLE are linked to disruptions in type I interferon metabolism.

Purpose of the Study:

• To explore the molecular basis of AGS and its relationship with SLE.
• To investigate the role of nucleases in endogenous nucleic acid metabolism and immune activation.
• To understand the implications for therapeutic strategies in AGS and related disorders.

Main Methods:

• Genetic analysis of patients with AGS and familial chilblain lupus.
• Investigation of nucleases involved in nucleic acid clearance.
• Comparative analysis of immune responses in AGS, congenital infections, and SLE.

Main Results:

• Heterozygous mutations in TREX1 (AGS1 gene) and SAMHD1 (AGS5 gene) are associated with familial chilblain lupus, a subtype of SLE.
• Mutations in TREX1 are the most frequent cause of monogenic SLE.
• Defective nucleases in AGS impair the removal of endogenous nucleic acids, triggering immune system activation.

Conclusions:

• A failure in endogenous nucleic acid removal by specific nucleases is a key mechanism in AGS.
• This mechanism explains the phenotypic similarities between AGS, congenital infections, and SLE.
• Urgent questions arise regarding the development and application of immunosuppressive treatments for AGS and related conditions.